INSIGHTS ON DRUG DEVELOPMENT
-
Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow
Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.
-
High-Throughput IgG Quantification Assay For Cell Line Development
Monoclonal antibodies are revolutionizing treatment for various diseases, which include cancer and autoimmune disorders. Discover how improving production methods can reduce costs and enhance accessibility.
-
Innovating The mAb Characterization Process
Understanding the characteristics of a molecule's "personality" is crucial for optimizing development and manufacturing. Learn how to overcome the challenges in the characterization process.
-
The Role Of A Consulting Firm In The IND Process
Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.
-
Can Collaboration Close Biopharma's Talent Gap For Good?3/17/2026
Biopharma innovation is accelerating, but workforce shortages threaten progress. See how strengthening collaboration is essential to developing the skills needed for emerging therapies.
-
Cracking Complexity: Learnings From 70+ Bispecific Antibody Programs6/9/2026
The goal is practical: help development teams make early decisions that balance speed, quality, and risk and support a smoother path to the clinic.
-
If Collaboration Fuels Biopharma Innovation, Why Can't We Connect More?3/17/2026
Breakthroughs thrive when biopharma teams work across silos, yet collaboration remains surprisingly difficult. Explore the barriers and why they persist. What will it take to move beyond them?
-
mTOR Pathway3/24/2025
Explore the mTOR signaling pathway and reveal how mTORC1 regulates cell growth, metabolism, and survival to ensure cellular function and adaptation to environmental cues.
-
Multiplex Imaging3/24/2025
Explore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.
DRUG DEVELOPMENT SOLUTIONS
-
AST’s line of table-top machines, GENiSYS® Lab, are ideal systems for drug product development and cGMP production applications. Each system is designed to automate the critical aseptic operations for vial, syringe and cartridge processing to reduce contamination risk and product variability. These table-top systems are engineered to have complete compatibility with cleanroom environments, including Laminar Air Flow Hoods, Bio-Safety Cabinets and aseptic isolators.
-
Developing ophthalmic drugs demands precision and compliance. Explore a specialized excipient portfolio that supports optimal formulation to enhance stability, sterility, and patient comfort.
-
Our comprehensive pharmaceutical development service offering includes new drug development, early stage formulation and analytical development for both highly potent and non-potent drug products.
-
Fluorescent Stereo Microscope Leica M165 FC
The Leica M165 FC fully apochromatic corrected stereo microscope with 16.5:1 zoom optics resolves structures down to 1.1 micron for detailed fluorescent imaging.
Image coding allows easy, convenient reproduction of image settings and parameters for fast, consistent, high quality observation and documentation.
TripleBeam technology dedicates a separate beam channel for fluorescence illumination to enhance image contrast, details and intensity for better performance.
-
Power. Potential. Productivity.
STELLARIS 5 is a completely re-imagined confocal microscope platform.
STELLARIS confocal microscopes can be combined with all Leica modalities, including FLIM, STED, DLS, and CRS. With the STELLARIS confocal platform, we have re-imagined confocal microscopy to get you closer to the truth.
- Power to see more
- Potential to discover more
- Productivity to do more